Dosage of Boxagrippal in details
Caplet: 200 mg: Adults and Children >12 years: Initial Dose: 2 caplets, then if necessary, 1 or 2 caplets every 4 hrs.
400 mg: Adults and Children >12 years: Initial Dose: 1 caplet, then if necessary, 1 caplet every 4 hrs.
It is recommended not to exceed 1,200 mg daily for minor ailments (eg, fever and headache) but can be used up to a maximum of 2,400 mg daily, if prescribed by the doctor.
Syrup: Boxagrippal for Children is suitable for babies and children from 3 months (weighing >5 kg), to be given orally. Daily Dose: 20-30 mg/kg body weight in divided doses.
Post-Immunisation Fever: Can be given to babies from 3 months old (weighing >5 kg), on the advice of a physician. Initial Dose: 2.5 mL followed by a further 2.5 mL 6 hrs later, if necessary. Not >5 mL in 24 hrs. Pain and Fever: Infants 3-6 months: 2.5 mL 3 times daily. Infants 6-12 months: 2.5 mL 3-4 times daily. Children 1-3 years: 5 mL 3 times daily. Children 4-6 years: 7.5 mL 3 times daily. Children 7-9 years: 10 mL 3 times daily. Children 10-12 years: 15 mL 3 times daily. Doses should be given approximately every 6-8 hrs, (or with a minimum of 4 hrs between each dose if required). Not suitable for children <3 months unless advised by physician.
Administration: Boxagrippal should be taken with or after food.
Boxagrippal should be used at the lowest effective dose for shortest possible time.
What other drugs will affect Boxagrippal?
Tell your doctor about all other medicines you use, especially:
-
a blood thinner such as warfarin (Coumadin, Jantoven);
-
steroids (prednisone and others);
-
diuretics (water pills), or medicines to treat high blood pressure;
-
a beta-blocker such as atenolol (Tenormin, Tenoretic), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Dutoprol, Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others;
-
an antidepressant such as amitriptyline (Elavil, Vanatrip, Limbitrol), doxepin (Sinequan), nortriptyline (Pamelor), and others; or
-
aspirin or other NSAIDs (non-steroidal anti-inflammatory drugs) such as Ibuprofen (Boxagrippal) (Advil, Motrin), naproxen (Aleve, Naprosyn, Naprelan, Treximet), celecoxib (Celebrex), diclofenac (Arthrotec, Cambia, Cataflam, Voltaren, Flector Patch, Pennsaid, Solareze), indomethacin (Indocin), meloxicam (Mobic), and others.
This list is not complete and other drugs may interact with Boxagrippal. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Boxagrippal interactions
Ibuprofen (Boxagrippal) should be avoided in combination with:
Aspirin: Unless low-dose aspirin (not above 75mg daily) has been advised by a doctor, as this may increase the risk of adverse reactions.
Experimental data suggest that Ibuprofen (Boxagrippal) may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. However, the limitations of these data and the uncertainties regarding extrapolation of ex-vivo data to the clinical situation imply that no firm conclusions can be made for regular Ibuprofen (Boxagrippal) use, and no clinically relevant effect is considered to be likely for occasional Ibuprofen (Boxagrippal) use.
Other NSAIDs as these may increase the risk of adverse effects.
Ibuprofen (Boxagrippal) should be used with caution in combination with:
Anticoagulants: NSAIDs may enhance the effects of anti-coagulants, such as warfarin.
Antihypertensives and diuretics: NSAIDs may diminish the effect of these drugs. Diuretics can increase the risk of nephrotoxicity of NSAIDs.
Corticosteroids: may increase the risk of adverse reactions in the gastrointestinal tract
Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): increased risk of gastrointestinal bleeding( see section 4.4)
Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.
Lithium: there is potential increase in plasma levels of lithium.
Methotrexate: there is a potential for an increase in plasma methotrexate.
Ciclosporin: increased risk of nephrotoxicity.
Mifepristone: NSAID should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.
Tacrolimus: possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.
Zidovudine: there is evidence of an increased risk of haemarthroses and haematoma in HIV (+) haemophiliacs receiving concurrent treatment with zidovudine and Ibuprofen (Boxagrippal).
Quinolone antibiotics: animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.
Pseudoephedrine (Boxagrippal)
Pseudoephedrine (Boxagrippal) may interact with the actions of other sympathomimetic drugs and the antibacterial agent furazolidone. The action of Pseudoephedrine (Boxagrippal) may be reduced by guanethidine, reserpine or methyldopa and may be reduced or enhanced by tricyclic antidepressants. Pseudoephedrine (Boxagrippal) may reduce the action of guanethidine and may increase the possibility or arrhythmias in patients taking digitalis, quinidine or tricyclic antidepressants
References
- DailyMed. "PSEUDOEPHEDRINE SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "IBUPROFEN: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- FDA/SPL Indexing Data. "7CUC9DDI9F: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Boxagrippal are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Boxagrippal. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
13 consumers reported frequency of use
How frequently do I need to take Boxagrippal?It was reported by ndrugs.com website users that Boxagrippal should ideally be taken Twice in a day as the most common frequency of the Boxagrippal. You should you adhere strictly to the instructions and guidelines provided by your doctor on how frequently this Boxagrippal should be taken. Get another patient's view on how frequent the capsule should be used by clicking here.
| Users | % | ||
|---|---|---|---|
| Twice in a day | 5 | 38.5% | |
| 3 times in a day | 4 | 30.8% | |
| 4 times in a day | 2 | 15.4% | |
| Once in a day | 2 | 15.4% | |
35 consumers reported doses
What doses of Boxagrippal drug you have used?The drug can be in various doses. Most anti-diabetic, anti-hypertensive drugs, pain killers, or antibiotics are in different low and high doses and prescribed by the doctors depending on the severity and demand of the condition suffered by the patient. In our reports, ndrugs.com website users used these doses of Boxagrippal drug in following percentages. Very few drugs come in a fixed dose or a single dose. Common conditions, like fever, have almost the same doses, e.g., [acetaminophen, 500mg] of drug used by the patient, even though it is available in various doses.
| Users | % | ||
|---|---|---|---|
| 101-200mg | 21 | 60.0% | |
| 201-500mg | 9 | 25.7% | |
| 11-50mg | 3 | 8.6% | |
| 51-100mg | 1 | 2.9% | |
| 1-5mg | 1 | 2.9% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
